Introduction A comprehensive peptide purity testing report must include validated chromatographic and mass spectrometric data to verify both chemical sequence […]
GC-MS vs LC-MS/MS for Nitrosamine Testing: How to Choose the Right Analytical Technique Read More »
Modern Analytical Platforms for Peptide Mapping and Sequence Analysis This section explains how high-resolution mass spectrometry combined with liquid chromatography
Peptide Mapping and Sequence Analysis Services for Biosimilars Read More »
The assessment of Extractables and Leachables (E&L) in biologic drug products remains one of the most significant safety and quality
Extractables and Leachables in Biologic Drug Products: Mass Spectrometry Approaches Read More »
Introduction Selecting Low-Leachables Packaging Materials for critical pharmaceutical and biopharmaceutical systems requires a structured, science-driven assessment of polymer thermodynamics, migration
How to Select Materials for Low-Leachables Packaging Systems Read More »
Understanding Why Biosimilars Fail Regulatory Approval: An Analytical Overview Biosimilars fail regulatory approval primarily because of deficiencies in chemistry, manufacturing,
Why Do Some Biosimilars Fail Regulatory Approval? The Most Common Development Pitfalls Read More »
Introduction: Understanding which analytical tests for biosimilar regulatory submission are mandatory is one of the most complex challenges in biologic drug development.
What Analytical Tests Are Mandatory for a Biosimilar Regulatory Submission? Read More »
Introduction to Mass Spectrometry Characterization of Peptide-Oligonucleotide Conjugates Mass spectrometry characterization of peptide-oligonucleotide conjugates is a sophisticated, multi-dimensional analytical approach
Introduction to Advanced Biosimilar Comparability Demonstrating analytical similarity is the cornerstone of biosimilar development, serving as the primary step in
LC-MS/MS Services for Biosimilar Comparability Studies Read More »
Global Market Dynamics and Generic Injectable Trends The global market for sterile injectables is undergoing a significant transformation, rapidly shifting
Future Trends in Generic Injectable Drug Development Read More »
Advanced Optimization in Biosimilar Formulation Development Service Stability A comprehensive biosimilar formulation development service stability program is designed to ensure
